ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 219 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $409,000 | -73.3% | 4,401 | -80.4% | 0.00% | -83.3% |
| Q2 2021 | $1,530,000 | +248.5% | 22,429 | +254.6% | 0.01% | +100.0% |
| Q1 2021 | $439,000 | -59.5% | 6,325 | -63.3% | 0.00% | -83.3% |
| Q2 2020 | $1,084,000 | +49.1% | 17,222 | +7.6% | 0.02% | +350.0% |
| Q4 2019 | $727,000 | +0.8% | 16,005 | +1.5% | 0.00% | -33.3% |
| Q3 2019 | $721,000 | -72.8% | 15,761 | -65.1% | 0.01% | -76.9% |
| Q2 2019 | $2,647,000 | +198.1% | 45,146 | +127.9% | 0.03% | +188.9% |
| Q1 2019 | $888,000 | +78.0% | 19,807 | +54.6% | 0.01% | +50.0% |
| Q4 2018 | $499,000 | -75.1% | 12,814 | -70.6% | 0.01% | -75.0% |
| Q3 2018 | $2,007,000 | +754.0% | 43,616 | +707.7% | 0.02% | +700.0% |
| Q2 2018 | $235,000 | -54.3% | 5,400 | -64.3% | 0.00% | -66.7% |
| Q4 2017 | $514,000 | – | 15,135 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |